Marex Group »

Celldex Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $223k 8.2k 27.16

More positions owned by Marex Group

Meta Platforms Cl A (META)
Tesla Motors (TSLA)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Booking Holdings (BKNG)
Apple (AAPL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Microsoft Corporation (MSFT)
Strategy Cl A New (MSTR)
Valkyrie Bitcoin (BRRR)
Home Depot (HD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Netflix (NFLX)

View all positions for Marex Group

Top funds holding Celldex Therapeutics

Wellington Management Company
Kynam Capital Management
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Commodore Capital
Deep Track Capital
Braidwell
Point72 Asset Management
Eventide Asset Management
Geode Capital Management
Eversept Partners
Millennium Management

View all funds holding Celldex Therapeutics